SCHEMBL8103529

SCHEMBL8103529

CC(C)Cc1nc(CC(C)C)n(Cc2ccc(Cc3cccc(C(=O)O)c3)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 1/20 0.44
AGTR2 P50052 1/20 0.44
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
MYC P01106 1/20 0.40
PLA2G2A P14555 1/20 0.39
IDO1 P14902 1/20 0.39
TDO2 P48775 1/20 0.39
FOLH1 Q04609 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
HTT P42858 1/20 0.38
ALOX5AP P20292 1/20 0.38
YTHDC1 Q96MU7 1/20 0.38
ROCK1 Q13464 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8096036 0.87 AGTR1 (0.48) AGTR1AGTR2SMN1; SMN2NPC1RAB9A
SCHEMBL8103506 0.85 CA1 (0.39) CA1CA2CA9MYCIDO1
SCHEMBL8105392 0.85 AGTR1 (0.40) AGTR1AGTR2CA1CA2CA9
SCHEMBL8105656 0.82 PPARG (0.47) AGTR1AGTR2CA1CA2CA9
SCHEMBL8103155 0.82 AGTR1 (0.54) AGTR1AGTR2CA1CA2CA9
SCHEMBL8095655 0.81 AGTR1 (0.42) AGTR1AGTR2
SCHEMBL8104901 0.80 AGTR1 (0.48) AGTR1AGTR2
SCHEMBL8109301 0.80 FOLH1 (0.43) CA1CA2CA9PLA2G2AIDO1
SCHEMBL8105272 0.79 AGTR1 (0.46) AGTR1AGTR2
SCHEMBL8111078 0.79 CA1 (0.42) AGTR1AGTR2CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed